Sustained Efficacy of Secukinumab in Patients With Moderate to Severe Palmoplantar Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sustained Efficacy of Secukinumab in Patients With Moderate-to-Severe Palmoplantar Psoriasis: 2·5-Year Results From GESTURE, A Randomized, Double-Blind, Placebo-Controlled Trial
Br J Dermatol 2019 Jul 08;[EPub Ahead of Print], AB Gottlieb, A Kubanov, M van Doorn, J Sullivan, KA Papp, R You, P Regnault, JA FruehFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.